Palo Alto, CA, United States of America

Kedar Gautam Patel

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kosan Biosciences Incorporated. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kedar Gautam Patel. Retrieved from https://idiyas.com/inventor/kedar-gautam-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kedar Gautam Patel: Innovator in Antiproliferative Agents

Introduction

Kedar Gautam Patel is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as antiproliferative agents.

Latest Patents

Kedar holds a patent for "2-Desmethyl ansamycin compounds." This patent describes 2-desmethyl ansamycins that possess a specific structure, where R, R, R, R, R, and R are defined within the patent. These compounds are recognized for their potential utility in combating cell proliferation.

Career Highlights

Kedar is currently associated with Kosan Biosciences Incorporated, a company that focuses on innovative biopharmaceuticals. His work at Kosan has been instrumental in advancing research in the field of cancer therapeutics.

Collaborations

Kedar has collaborated with esteemed colleagues, including Zong-Qiang Tian and Robert G McDaniel. These partnerships have contributed to the successful development of his patented compounds.

Conclusion

Kedar Gautam Patel's work exemplifies the intersection of innovation and healthcare, showcasing the importance of research in developing new therapeutic agents. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…